Literature DB >> 16436135

Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells.

M T Krauth1, Y Majlesi, K Sonneck, P Samorapoompichit, M Ghannadan, A W Hauswirth, M Baghestanian, G H Schernthaner, C Worda, M R Müller, W R Sperr, P Valent.   

Abstract

BACKGROUND: Statins are inhibitors of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase, a key enzyme in mevalonic acid (MVA)-dependent signaling. Recent data suggest that statins exhibit profound inhibitory effects on growth and function of various immune cells. In the present study, we examined the in vitro effects of five different statins on primary human mast cells (MCs), MC progenitors, and the human MC line HMC-1.
METHODS: Histamine release experiments were conducted on isolated MCs using statins and an anti-immunoglobulin E (IgE) antibody. Culture experiments were performed with stem cell factor (SCF) and interleukin (IL)-6, and cord blood-derived progenitors.
RESULTS: Preincubation of primary lung MCs with cerivastatin or atorvastatin (1-50 microM) for 24 h resulted in inhibition of anti-IgE-induced release of histamine. The effects of both statins were dose-dependent. Moreover, both statins, and to a lesser degree lovastatin, were found to inhibit the SCF-induced differentiation of MCs from their progenitors. The other statins tested (simvastatin, pravastatin) did not affect mediator release or growth of MCs.
CONCLUSIONS: Cerivastatin and atorvastatin act as inhibitors of growth and function of human MCs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436135     DOI: 10.1111/j.1398-9995.2006.00997.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  12 in total

1.  Selective IgE deficiency and cardiovascular diseases.

Authors:  Eli Magen; Joseph Mishal; Daniel Vardy
Journal:  Allergy Asthma Proc       Date:  2015 May-Jun       Impact factor: 2.587

Review 2.  Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism.

Authors:  Michael B Fessler
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

3.  Fluvastatin enhances IL-33-mediated mast cell IL-6 and TNF production.

Authors:  Marcela T Taruselli; Elizabeth Motunrayo Kolawole; Amina Abdul Qayum; Tamara T Haque; Heather L Caslin; Daniel Abebayehu; Sydney A Kee; Jordan M Dailey; Kaitlyn G Jackson; Jason R Burchett; Andrew J Spence; Neha Pondicherry; Brian O Barnstein; Gregorio Gomez; David B Straus; John J Ryan
Journal:  Cell Immunol       Date:  2021-11-24       Impact factor: 4.868

Review 4.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

Review 5.  Twenty-first century mast cell stabilizers.

Authors:  D F Finn; J J Walsh
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 6.  Targeting the airway smooth muscle for asthma treatment.

Authors:  Blanca Camoretti-Mercado
Journal:  Transl Res       Date:  2009-07-14       Impact factor: 7.012

7.  Intraoperative myocardial infarction: Kounis syndrome provoked by latex allergy.

Authors:  Veronica Marcoux; Shravan Nosib; Henry Bi; Brian Brownbridge
Journal:  BMJ Case Rep       Date:  2013-01-08

Review 8.  Molecular targets of statins and their potential side effects: Not all the glitter is gold.

Authors:  Kush K Patel; Viren S Sehgal; Khosrow Kashfi
Journal:  Eur J Pharmacol       Date:  2022-03-20       Impact factor: 4.432

9.  Intratracheal instillation of pravastatin for the treatment of murine allergic asthma: a lung-targeted approach to deliver statins.

Authors:  Amir A Zeki; Jennifer M Bratt; Kevin Y Chang; Lisa M Franzi; Sean Ott; Mark Silveria; Oliver Fiehn; Jerold A Last; Nicholas J Kenyon
Journal:  Physiol Rep       Date:  2015-05-11

Review 10.  Mast cells in vulnerable atherosclerotic plaques--a view to a kill.

Authors:  Ken A Lindstedt; Mikko I Mäyränpää; Petri T Kovanen
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.